William E. Gillanders

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

Matthew M. Gubin, Xiuli Zhang, Heiko Schuster et al. · Nature · 2014 · 2K citations · Full text

Life Sciences, Immunology, Oncology +10

Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts

Shunqiang Li, Dong Shen, Jieya Shao et al. · Cell Reports · 2013 · 625 citations · Full text

Medicine, Genetics, Oncology +14

cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity

Stephen T. Ferris, Vivek Durai, Renee Wu et al. · Nature · 2020 · 587 citations · Full text

Medicine, Immunology, Oncology +14

EpCAM Is Overexpressed in Breast Cancer and Is a Potential Target for Breast Cancer Gene Therapy

Walid Osta, Kaidi Mikhitarian, Michael Mitas et al. · Cancer Research · 2004 · 565 citations

Medicine, Molecular Biology, Oncology +14

Targeting both tumour-associated CXCR2⁺ neutrophils and CCR2⁺ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma

Timothy M. Nywening, Brian A. Belt, Darren R. Cullinan et al. · Gut · 2017 · 481 citations · Full text

Medicine, Immunology, Oncology +17